Published in Hematology Week, October 27th, 2008
"Since the case showed a marked reduction of tumor load, direct anti-tumor effects of CEP to myeloma cells were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.